Mollugin enhances the osteogenic action of BMP-2 via the p38–Smad signaling pathway

Seong Hee Moon, Ikyon Kim, Seong Hwan Kim

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)


Bone morphogenetic protein 2 (BMP-2) has been used clinically to encourage bone regeneration; although, there can be major side effects with larger doses. Therefore, there is a need to identify new small molecules to potentiate the osteogenic action of BMP-2. In this study, we investigated the effect of mollugin on bone formation in murine bi-potential mesenchymal progenitor C2C12 cells by combination with BMP-2. We found mollugin could enhance the BMP-2-mediated osteoblast differentiation of C2C12 cells. This was accompanied by the induction of other osteogenic BMPs. We also found the enhancing potential of mollugin may involve activation of the p38–Smad1/5/8 signaling axis. Furthermore, mollugin promoted skeletal development in zebrafish. The combination of BMP-2 with small molecules, including mollugin, could minimize its clinical limitations, and these molecules might lead to the development of effective stem cell stimulants for bone regeneration and fracture healing.

Original languageEnglish
Pages (from-to)1328-1335
Number of pages8
JournalArchives of pharmacal research
Issue number11
Publication statusPublished - 2017 Nov 1

Bibliographical note

Funding Information:
Acknowledgements This work was supported by a project Grant (KK1703-F02) from the Korea Research Institute of Chemical Technology.

Publisher Copyright:
© 2017, The Pharmaceutical Society of Korea.

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Drug Discovery
  • Organic Chemistry


Dive into the research topics of 'Mollugin enhances the osteogenic action of BMP-2 via the p38–Smad signaling pathway'. Together they form a unique fingerprint.

Cite this